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Optical Magnetic Induction 
Tomography of the Heart
Luca Marmugi & Ferruccio Renzoni
Atrial Fibrillation (AF) affects a significant fraction of the ageing population, causing a high level of 
morbidity and mortality. Despite its significance, the causes of AF are still not uniquely identified. 
This, combined with the lack of precise diagnostic and guiding tools, makes the clinical treatment 
of AF sub-optimal. We identify magnetic induction tomography as the most promising technique 
for the investigation of the causes of fibrillation and for its clinical practice. We therefore propose 
a novel optical instrument based on optical atomic magnetometers, fulfilling the requirements for 
diagnostic mapping of the heart’s conductivity. The feasibility of the device is here discussed in view 
of the final application. Thanks to the potential of atomic magnetometers for miniaturisation and 
extreme sensitivity at room temperature, a new generation of compact and non-invasive diagnostic 
instrumentation, with both bedside and intra-operative operation capability, is envisioned. Possible 
scenarios both in clinical practice and biomedical research are then discussed. The flexibility of the 
system makes it promising also for application in other fields, such as neurology and oncology.
Cardiac arrhythmias are heart conditions characterised by irregular, slow, or accelerated, beating of the heart. 
Their causes are related to abnormal generation and conduction of the electrical pulses that control the heart’s 
activity1.
Among the most diffused sustained arrhythmias are atrial fibrillation (AF), which affects more than 10% of 
population over 70, and ventricular fibrillation (VF). They manifest as a turbulent cardiac activity and represent 
one of the most important causes of morbidity and mortality in rich countries2.
Nevertheless, little is known about the fundamental causes and mechanisms of fibrillation; consequently, the 
clinical treatment of these conditions, either via drug therapy3 or surgical procedure, is sub-optimal4. In particu-
lar, radio-frequency catheter ablation (RFCA) in AF has an estimated success rate of ~50% after 1yr, and multiple 
procedures are often required5.
Among the reasons of such discouraging statistics, a central role is played by the lack of: i. insight on the 
fundamental triggers and supporters of the fibrillation, ii. effective clinical assessment and evaluation, and iii. 
surgery-guiding tools. This is mainly due to the absence of tailored and effective diagnostic methods. In fact, 
magnetocardiography (MCG) and electrocardiography (ECG) do not provide any direct information about the 
causes of the irregular beat and, more importantly, the structures producing it. Recently, the first indications of 
localised stable sources were found in patients referred for AF, both in the frequency6 and in the time7,8 domains. 
It was then argued that fibrillation is caused by permanent modifications of the heart’s local conductivity, which 
produce deterministic sources known as rotors, and by the stochastic interaction with the local anatomy, which 
creates randomly distributed re-entry paths (wavelets). However, the topic is still widely debated9.
In this paper, magnetic induction tomography (MIT) is proven to be the ideal tool to investigate the causes 
and the mechanisms of fibrillation. In fact, it generates a non-invasive, space-resolved map of the heart’s con-
ductivity, thus addressing directly the presence of permanent conduction anomalies and their relationship with 
the generation and the dynamics of AF and VF. In order to meet the requirements for such an instrument, we 
design an MIT imaging system based on optical atomic magnetometers (OAMs). OAMs solve the sensitivity 
and bandwidth issues of standard MIT systems based on pick-up coils and similar technologies, and will provide 
flexible, efficient and robust detection of the MIT signal, in unshielded environment and at room temperature. 
The proposed instrument has the potential for bedside tomography capability, with expected impact also on the 
screening and monitoring of patients, and in the AF surgery planning and navigation.
A novel class of non-invasive diagnostic tools, which will fulfil the need of dedicated resources for AF, VF and 
other conditions where electrical properties play a major role, can be thus envisioned.
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Results
Conductivity Mapping via Magnetic Induction Tomography. Magnetic induction tomography is a 
recently developed technique for the investigation of the electrical and magnetic properties of an object10. It 
provides a direct mapping of conductivity σ, permittivity ε and permeability μ, without requiring any physical 
contact. It finds applications in detection of metallic objects, either for screening11, or for non-destructive evalua-
tion of quality and integrity in industrial processes12. It was recently proposed also for the localisation of cerebral 
haemorrhages13.
MIT exploits the response of the object of interest to an AC magnetic field (primary field, B1). This field excites 
eddy currents in the sample, which produce a secondary field (B2), opposing B1. The magnitude and phase of 
the total magnetic field (Btot, see Fig. 1) depend on the object’s electrical and magnetic properties: by performing 
position-resolved measurements of Btot, the dielectric characteristics of the sample can be effectively mapped.
If the penetration depth of the primary field is larger than the thickness of the object of interest, then the sec-
ondary field, oscillating at the frequency ω, can be estimated as14:
ω ωµ ωε ε σ µ ω= − − + −Q i PB B( ) { [ ( 1) ] ( 1)} ( ) , (1)r r2 10 0
where Q and P are geometrical factors, εr is the relative permittivity, and μr is the relative permeability. Here, εr, μr 
and the electrical conductivity depend on the object of interest; hence, the possibility of mapping its characteris-
tics. It is worth noting that σ produces a purely imaginary contribution and, therefore, can be effectively isolated 
from other terms14, as described in the following.
Hence, we propose here MIT as the most promising solution for non-invasively addressing the conductivity of 
biological tissues and, in particular, of the heart. In fact, alternative hybrid approaches based on magneto-acoustic 
tomography with magnetic induction (MAT-MI) are mainly sensitive to steep changes of conductivity and rely on 
the coupling between large magnetic field excitation of eddy current and acoustic waves15. In addition, given the 
underlying assumption of acoustic homogeneity, they appear not suited for mechanically composite structures 
like the human thorax16.
In standard magnetic induction tomography, a driven coil produces B1; a set of coils then detects the mag-
netic field perturbed by the object of interest. However, such devices suffer from the drawbacks and limitations 
of the coils: indeed, the ultimate performance of MIT depends on the magnetic field sensor’s characteristics. 
Conventional systems therefore have limited sensitivity at low frequencies, do not provide enough bandwidth to 
adapt to different, non-conductive objects, and cannot be reduced below the physical size of the pick-up coil, thus 
limiting also the spatial resolution. In addition, they require a physical connection (i.e. wiring) with the read-out 
electronics and a dedicated calibration. All these facts unfortunately prevent the realisation of a working device 
for the MIT imaging of the heart.
Sensitive detection with Optical Atomic Magnetometers. The limitations in sensitivity and spatial 
resolution of the conventional MIT devices can be overcome by using OAMs for the detection of the secondary 
field produced by the eddy currents.
An optical atomic magnetometer is essentially a sample of atoms, optically pumped in a known quantum 
state sensitive to the external magnetic field, and probed by a resonant laser. Under the influence of the external 
magnetic field, atoms undergo Larmor precession17. In an external field B, atomic spins precede at frequency ωL, 
directly proportional to the modulus of the magnetic field:
ω γ= B, (2)L
where:
γ = .
eg
m2 (3)
e
e
Here, e is the electron’s fundamental charge, me its rest mass, and ge = − 2(1 + α/(2π) + o(α2)), with α ≈ 1/137 
the fine structure constant.
As a consequence of the atomic precession, the optical response of the atomic sample is changed. Such modi-
fications can be detected by analysing the polarisation of a resonant probe beam: according to Eq. 2, the measure-
ment of the magnetic field is effectively and robustly translated to a measurement of frequency.
OAMs can reach extreme sensitivity (better than − T Hz10 /15 ), comparable to the performances of 
super-conductive quantum interference devices (SQUIDs)18. Contrary to SQUIDs, OAMs are capable of room 
temperature and unshielded operation, they have an extreme potential for miniaturization19, and they do not 
Figure 1. MIT principle: relationship between primary (B1) and secondary (B2) fields. 
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require any calibration, as a consequence of Eqs 2 and 3. In addition, which is particularly appealing for the MIT 
application discussed here, their bandwidth is not limited by intrinsic factors and their sensitivity can be up to 107 
times larger than that of a standard pick-up coil of the same size below 50 MHz20. Finally, OAMs do not require 
physical contact between the actual sensor, i.e. the atomic vapour, and the read-out electronics, and they are suit-
able for an array arrangement.
OAMs-based MIT. We propose to produce the MIT primary field B1 with an array of coils placed above the 
patient’s chest, roughly ~10 cm above the skin, as this distance has been already demonstrated to not affect the 
MIT measurement21. Nevertheless, different positioning and arrangement are possible. In particular, the exciting 
coil can be integrated within a catheter and thus inserted directly in the patient’s heart during the RFCA.
The MIT coil is driven by an AC current supply, with tuneable frequency in the range of ν = −MHz1AC  
MHz102 . The power requirements for the current supply (RF in Fig. 2) can be easily met by commercial devices: 
magnetic fields of the order of B1 ≤ 102 mG, thus much smaller than the ones required for other techniques such 
as MAT-MI15,16, should be sufficient for imaging. In the endoscopic arrangement, one can also take advantage of 
the same source used for the RFCA, by suitably decreasing its power for the imaging and then increasing it up to 
50 W for the scarring procedure4.
The total magnetic field Btot is detected by an array of optically pumped radio-frequency (RF) OAMs22. 
Different setups can be designed23–25 and effectively integrated in the MIT system. However, we propose here the 
arrangement with the least stringent requirements and the smallest footprint. The core of the measuring appara-
tus is thus an array of RF atomic magnetometers, operating in MIT modality. A sketch of the proposed setup is 
shown in Fig. 2, in the case of the simple planar geometry.
After the interaction with the preceding atomic vapour, the probe beam’s polarisation is rotated, with the 
polarisation oscillating at the Larmor frequency. The measurement of Btot and hence of B2, related to the local 
conductivity of the heart, is effectively and robustly reduced to the measurement of the probe’s polarisation 
oscillation. A balanced photodiode (see Fig. 2) for each cell of array generates a correspondingly modulated 
electrical signal.
The output of the OAMs is selectively amplified by a dual-phase, multi-channel lock-in amplifier, referenced 
to the RF waveform driving the primary field. This allows rejection of the background noise and thus detection, 
in unscreened environments, of the contributions due to the secondary field only21. In particular, both amplitude 
and phase lag of B2 with respect to B1 will be measured, so to reconstruct the conductivity of the tissue under 
investigation. The relative phase, due to imaginary terms directly related to σ (Eq. 1), allows the creation of 
conductivity maps of the heart. This is, as anticipated, the most appealing advantage of OAMs-based MIT, and 
a fundamental prerequisite for the use of the device in the common clinical practice and in operating theatres.
The amplified signals produced by the phase-sensitive detection system are fed to a multi-channel DAQ board 
connected to a computer. Here, raw data are stored and processed by a dedicated software.
In view of the realisation of a practical device, it is worth noting that the OAMs array can be designed in a 
compact and integrated device, by exploiting also optical fibres links and integrated waveguides, thus contain-
ing the footprint. Moreover, it is important to underline that the 3D image reconstruction via the solution of 
the inverse problem26,27 would require a more structured array and excitation scheme than the planar geometry 
shown in Fig. 2.
In this case, the tissues of interest will be displayed by a computer screen as 3D conductivity maps, unlike 
other non-invasive mapping techniques based on electric signals8. In other words, a 3D representation of the 
Figure 2. OAMs-based MIT of the heart: possible setup. (a) Arrangement for bedside operation. RF: radio-
frequency current supply; LIA: lock-in amplifier; DAQ: data acquisition board; PC: computer. (b) Detailed view 
of the OAMs’ array and MIT coils in planar geometry. Eddy currents produced in the heart are represented 
as white loops. B2 is depicted as a vector oriented towards the heart. (c) Detail of the OAM sensor unit. BS: 
beam-splitter; PBS: polarising beam-splitter; M: mirror; BPD: balanced photodiode. Coils are not shown for 
simplicity. More details can be found in Methods. The heart sketch is an adaptation of an image released under 
Creative Commons Attribution 2.5 License 2006. Credits are to Patrick J. Lynch, medical illustrator, and C. Carl 
Jaffe, MD, cardiologist.
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heart will be provided, with local “bright” spots indicating the areas of increased conductivity. The RF ablation of 
such areas will produce a dramatic decrease of the local conductivity, and hence an observable change in the map. 
Cross-sections of the 3D map can be isolated for further diagnostic or subsequent investigation. Time-resolved 
maps and models can be created, in order to study the evolution of the conductivity before and after the RFCA.
Feasibility. The feasibility of MIT measurements with an OAM was recently demonstrated21; promising 
results were obtained in terms of sensitivity, operation in unshielded environment, imaging and spatial resolu-
tion33. However, for the present proposal, major concerns arise about the penetration of the primary magnetic 
field and the tomography capability.
Penetration capability. The skin depth, which regulates the penetration of an AC field in a medium, in the 
case of poor conductors at high frequency, is given by28:
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where ω = 2πνAC is the field’s angular frequency; μ = μ0μr is the magnetic permeability, ε = ε0εr is the electric 
permittivity, and ρ = 1/σ is the resistivity of the medium.
Resistivity and relative permittivity of the human heart are here computed and shown in Fig. 3, in the band 
between 1 HZ and 100 MHz, under the assumption of non-magnetic response, i.e. μr ≡ 1.
The penetration of the MIT primary field B1 is investigated in detail. By using the procedure described in 
Methods, ρ, εr and δ are computed for human tissues typically involved in the imaging of the heart: skin, fat, 
muscle and bone.
The resistivity of bones and fat is much larger than that of other tissues (see also Table 1), independently from 
the water and minerals content. In particular, there is a significant difference with respect to the heart, which 
implies that an almost negligible contribution, compared to that of the cardiac tissue, will be observed from those.
The relative attenuation of the MIT field B1 along the zˆ direction, ideally penetrating inside the patient’s chest 
is given by:
∑ω∆ = = .δ ω
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− −z eB
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In Eq. 5, a sum is performed over the different layers of gas (i.e. air) and tissues encountered by the AC pri-
mary field traveling to the heart; each layer is located between a top position z( )i
t( )  and a bottom one z( )i
b( ) , so that 
− ≡z z hi
b
i
t
i
( ) ( )  (Table 1).
Results shown in Fig. 4 demonstrate the feasibility of MIT measurement of the human heart.
Figure 3. Computed resistivity (ρ, (a)) and relative permeability (εr, (b)) of the health human cardiac tissue 
in the [1, 108] Hz band. 
Tissue ρ(Ωm) εr δ(m) h(mm)
Skin (dry) 0.11 107.1 0.024 1.8
Fat 26.2 14.5 0.58 4.8
Muscle 1.3 71.3 0.28 7.2
Bone 5.3 × 105 17.7 ≫ 10 12 (sternum)
Table 1.  Computed ρ, εr, δ at 50 MHz and expected thickness (h) of the human tissues surrounding the 
heart.
www.nature.com/scientificreports/
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The attenuation of the primary field becomes, as expected, larger with increasing frequency νAC; however, 
B1 will be reduced by ~20% at the surface of the heart at 100 MHz, thus allowing an effective excitation of eddy 
currents. Furthermore, bones and fat result almost completely transparent to electromagnetic excitations in the 
MHz band. Therefore, the OAM-based MIT instrument is insensitive to screening effects, unlike purely electrical 
methods like the ECG, whose signal can exhibit large variations among different patients. It is worth noting also 
that air (at z < 0 in Fig. 4) is completely transparent in this band.
According to Fig. 4, the largest attenuation of the driving field is predicted within the heart itself: the instru-
ment, consequently, will be highly sensitive to the heart’s response. In addition, this allows for a fine control of the 
penetration depth with the frequency νAC, as described in the next section.
The secondary field B2 will experience an analogous attenuation while traveling from the heart to the sensor, 
given the fact that its oscillation will be at the frequency of the primary field. In addition, possible diffraction 
effects at the boundaries between different tissues do not represent an issue: the present approach relies on a 
relative measurement of the conductivity and, therefore, systematic effects due to the specificity of the patient’s 
anatomy will not hamper the investigation. Moreover, image reconstruction and rejection of possible artefacts 
can be implemented and optimised.
It is worth noting that, within the validity of Eq. 1, the conductivity term is about 5 times larger than the per-
mittivity one at 1 MHz and about 3.4 times at 50 MHz. Therefore, although not completely negligible, spurious 
contributions to the secondary field will not hamper the measurement of σ.
Tomography capability. By exploiting Eq. 4, the effect of frequency change on the penetration of the MIT 
primary field B1 in the heart is simulated. Results are shown in Fig. 5, in the range νAC = 1 − 100 MHz.
Figure 5 proves the potential for the effective tomographic operation of the proposed instrument: by selecting 
the frequency of B1, it is possible to achieve different penetrations in the patient’s heart, and, therefore, to map the 
cardiac tissues’ conductivity at different depths. In particular, since the tuning of νAC can be practically continu-
ous, a fine control on the penetration depth can be achieved. This, together with the higher sensitivity to the car-
diac tissue’s characteristics, makes our instrument suitable also for the localisation of abnormally conducting 
regions within the bulk of the heart. Incidentally, Fig. 5 further demonstrates that B2 can propagate throughout 
the bulk of the heart, which has a cross-section along zˆ of ~7 cm.
These results are possible only thanks to the broad bandwidth of the OAMs’ array, by taking advantage of the 
OAMs’ efficient suppression of the 1/f noise and negligible inertia of the atomic precession. This would allow 
also a multi-frequency approach11, so to perform subtraction imaging either for the elimination of spurious 
Figure 4. Simulation of the relative attenuation of B1 in the human heart’s MIT imaging. From top to 
bottom: red 1 MHz; blue 10 MHz; black 50 MHz; green 100 MHz.
Figure 5. Tomography of the heart: simulation of the penetration depth in human heart, as a function of 
the primary field’s frequency. 
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contributions, such as prosthetics, reconstruction plates or other surgical devices, or for the investigation of spe-
cific phenomena and conditions.
This would not be possible, for example, with MAT-MI, where the limited bandwidth of the acoustic trans-
ducer and the sensitivity of acoustic waves to scattering by the body’s structures16 would limit the effective pene-
tration and, in particular, likely hamper the investigation of the heart’s conductivity.
Spatial and temporal resolution. Spatial resolution of the order of a few mm was experimentally 
achieved21. The proposed instrument hence has the potential for spatial resolution comparable or better than 
that of other experimental techniques such as endoscopic electrodes7. In addition, our device does not require 
the adhesion to the patient’s body or to the inner heart’s surface, with obvious advantages in terms of stability and 
repeatability of the measurement, and its spatial resolution does not depend on the exciting frequency, unlike the 
case of MAT-MI15.
It is worth recalling that the size of an average scarring during RF ablation is > 5 mm: on the one hand, there-
fore, the spatial resolution reached by our proof-of-principle system21 is sufficient; on the other hand, an improve-
ment in spatial resolution will allow a more precise ablation procedure, and ultimately a containment of collateral 
damage. In this view, the array arrangement and the possibility of increasing its density will have a relevant 
impact. Furthermore, it can be speculated that, with an optimised design of the array in view of the solution of the 
inverse problem, the final spatial resolution could be further improved.
Finally, given the different time scales of the processes involved, our system has the capability to reject 
spurious contributions due to the patient’s activity and heart’s movements. In fact, the normal heart’s 
beat rate can be approximated as 1 Hz, breath rate as 0.5 Hz, while the MIT OAM system will operate in the 
νAC = 1 MHz − 102 MHz band. Hence, to a first approximation, the heart’s natural motion will not be a limiting 
factor for the spatial resolution and suitable averaging sequences can be implemented. In particular, the mini-
mum time scale of the OAMs is of the order of 2π/ωL; in the case of the MIT operation, this lower limit can be 
estimated as 1/νAC. Both are much shorter than the average duration of the involved biological processes.
Discussion
The proposed application is technically feasible only thanks to the use of the optical atomic magnetometers’ array; 
however, the OAMs’ characteristics will also provide several advantages also in the daily clinical practice. The 
direct mapping of the heart’s conductivity, indeed, allows to address simultaneously the anatomy, the physiology 
and the pathology of the heart, thus filling up the lack of dedicated diagnostic tools.
The approach is completely non-invasive and harmless for the patient and the operator: AC magnetic fields 
will be roughly 105 times smaller than the typical Magnetic Resonance Imaging (MRI) field. Moreover, unlike 
MRI, our system is inherently safe also for other devices, such as diagnostic and medical (e.g. pace-makers) 
equipment.
Unlike ECG, the OAM MIT will not be affected by the body’s screening effects or contingent anomalies in the 
environment; it will not require contact with the patient, which can be important in the case of infective diseases, 
extended wounds, or burns on the chest. Furthermore, unlike SQUIDs, the system can be operated in unshielded 
environments and at room temperature; it has indeed the potential for actual bedside operation.
The diagnosis of fibrillation and its monitoring during surgery currently require an ongoing crisis; hence, 
for example, AF is induced during the RFCA procedure6–8. Our instrument, instead, is capable of detecting the 
sustaining structures even in absence of a fibrillation event. Novel procedures can thus be envisioned and large 
scale screening campaigns can be designed, as well as event-triggered monitors, for example with standard ECG, 
in order to get more insight on the fundamental mechanisms leading to AF or VF.
At the same time, the OAM MIT provides a new tool for: i. assessment of patients suitable for surgery, ii. 
surgery planning and design, and iii. surgery navigation and control, without the need of X-ray based imaging 
techniques, such as fluoroscopy, and with minimum occupation of the surgical field.
Finally, the proposed instrument is suitable also for the investigation of other body’s tissues and the diagnosis 
of specific conditions, where conductivity is, or is expected to be, an important parameter. Among the possi-
ble examples: peripheral nerves in neurodegenerative conditions, optic nerve in optic neuropathy and neuritis, 
skin healing after grafts, burns, or wounds, and detection of anomalous structures, such as early stage melano-
mas. Moreover, indications of a correlation between specific tumours and change of the electric properties of the 
malignant tissue were found in the context of RF-induced hyperthermia: with a cancer, the conductivity of liver 
and lung tissues increases by more than 30%, and by more than 500% in the case of mammary tissue29. If such 
data are confirmed, non-invasive maps of tissues’ conductivity will likely provide an early diagnosis and localisa-
tion of tumours, with a potential dramatic impact on the treatments’ effectiveness.
In conclusion, MIT is here identified as the ideal technique for shading new light on cardiac fibrillation. 
Therefore, an instrument based on an array of optical atomic magnetometers for magnetic induction tomography 
of heart is proposed. MIT allows the non-invasive and harmless mapping of the heart’s conductivity. OAMs over-
come the limitation of the current MIT instrumentation, mainly in terms of sensitivity, footprint, scalability and 
flexibility. In addition, the capability of OAMs of operation at room temperature and without dedicated shielding 
will ease the transfer of the technology from the laboratory to the clinical environment.
Our results indicate that the system will have the capability to operate in the required regime, with sufficient 
spatial resolution and in a real tomography mode, by simply adjusting the driving frequency. The merge of MIT 
and OAMs will thus provide a novel diagnostic tool, with no equal currently available. The device will improve the 
patients’ management in the case of heart conditions, by offering new research and clinical solutions, and the pos-
sibility of an effective patient-tailored diagnostic technique. This will increase the success rates of the treatment of 
fibrillations6 and clarify their underlying mechanisms.
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Finally, the device is a promising asset also for investigations on the conductivity anomalies in other condi-
tions of the nerves, skin and other organs and tissues, such as liver and breast. A relevant impact on the early 
diagnosis and localisation of peripheral neuropathies, structural anomalies, degenerative conditions and tumours 
can be therefore envisioned.
Methods
Experimental design: RF OAM for MIT. The atomic vapour is contained in cubic glass cells, so to allow 
optical access from four sides; a naturally occurring isotopic mixture of Rb can be used, with a few Torr of a noble 
buffer gas, in order to increase the interaction time and reduce the depolarising atom/wall collisions.
A distributed Bragg reflector laser, chosen in order to achieve the maximum stability and portability, is tuned 
to the F = 2 → F′ = 3 hyperfine transition of 87Rb D2 line, at 780 nm. The laser beam is split in a pair of pump and 
probe beams for each cell of the array. The pump is circularly polarised (σ+). A pair of Helmholtz coils with the 
axis parallel to kpump, the wavevector of the pump beam, allows optical pumping to the |F = 2, mF = + 2〉 Zeeman 
sub-level of the 87Rb ground state. Consequently, long-living atomic orientation of the ground state is created.
The probe beam is linearly polarised (π) perpendicularly to kpump and kprobe, the wavevectors of pump and 
probe laser beams, respectively. The beams are crossed at the centre of each cell. The actual size of the sensor is 
given by the overlapping of the two beams and, thus, can be easily adapted to the experimental requirements, 
also in view of the miniaturisation of the device. By assuming a beam waist of 4 mm in the centre of each 
vapour cell, about 210 μW of circularly polarised light are sufficient to saturate the transition =F 2, 
= = + → ′ = = +F m F m2, 2 3, 3F F 30. The probe beam, consistently, should have a power of the order of a 
few tens of μW: the minimum total power requirement for each cell in the OAMs’ array is therefore ~250 μW. This 
implies that a large array can be easily driven by a single laser source.
A radio-frequency magnetic field, perpendicular to the plane where kpump and kprobe lie, drives coherently the 
ground-state population’s polarisation. In view of applications, with a suitable arrangement, the RF coil can be 
integrated with the MIT primary coil33.
Dielectric properties of thoracic tissues. Dielectric properties of biological tissues are the result of the 
forced motion of electrolytes in the intra- and intercellular volumes. In particular, in the MHz band, the conduc-
tivity is mainly determined by mobility and molar concentration of ions. Experimental data reported in litera-
ture about biological tissues in vivo are often incomplete, or exhibit large fluctuations. Therefore, the frequency 
dependence of ρ and εr is here computed with the Cole-Cole equation31:
∑ε ω ε
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where ε∞ is the electric permittivity at high frequencies ωτ ( 1), while εs is the quasi-static permittivity 
ωτ ( 1); σionic is the static ionic conductivity. τn is n − th relaxation time and {αn} is a set of phenomenological 
parameters describing the broadening of the n − th contribution. In fact, the tissues’ response to oscillating elec-
tric and magnetic fields is empirically characterised by four regions with different polarisation characteristics, in 
particular with different relaxation times, τn.
From Eq. 6, ρ(ω) and εr(ω) can be directly computed:
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In order to obtain a more consistent estimation of ρ(ω), the frequency dependence, given by Eq. 7, is re-scaled 
with the average values reported in literature32. In the case of relative permittivity εr, to the best of our knowl-
edge, such comprehensive investigations cannot be found. Therefore, data as obtained by Eq. 8 are taken into 
consideration.
Results concerning tissues located in the human chest are summarised in Table 1, at 50 MHz.
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